0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Volatile Inhalational Anesthetics Market Research Report 2026
Published Date: 2026-01-16
|
Report Code: QYRE-Auto-21T20064
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Volatile Inhalational Anesthetics Market Research Report 2026
BUY CHAPTERS

Global Volatile Inhalational Anesthetics Market Research Report 2026

Code: QYRE-Auto-21T20064
Report
2026-01-16
Pages:130
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Volatile Inhalational Anesthetics Market Size

The global Volatile Inhalational Anesthetics market was valued at US$ 1055 million in 2025 and is anticipated to reach US$ 1375 million by 2032, at a CAGR of 3.9% from 2026 to 2032.

Volatile Inhalational Anesthetics Market

Volatile Inhalational Anesthetics Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Volatile Inhalational Anesthetics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Volatile inhalational anesthetics are halogenated organic liquids that readily vaporize and are delivered as a controlled concentration in a patient’s inspired gases through an anesthesia machine and vaporizer to produce general anesthesia. After inhalation, they diffuse from the lungs into the bloodstream and then into the brain, where they cause unconsciousness, amnesia, and varying degrees of immobility and analgesia; anesthesiologists adjust their effect quickly by changing the inspired concentration and by managing ventilation, making them useful for induction (in selected patients) and especially for maintenance of anesthesia during surgery. Common modern agents include sevoflurane, desflurane, and isoflurane, and their clinical use is balanced against side effects such as dose-dependent drops in blood pressure, respiratory depression, postoperative nausea, rare malignant hyperthermia susceptibility, and increasing attention to occupational exposure control and their greenhouse-gas footprint. The product has an average price of $200-350 per kilogram and a production volume of approximately 4,000 tons per year.
Upstream for volatile inhalational anesthetics begins with basic petrochemical feedstocks that are converted into highly fluorinated/halogenated intermediates using specialty reagents (notably fluorinating and chlorinating agents), catalysts, and tightly controlled reaction and purification steps, because these products must meet very high purity and stability requirements under pharmaceutical GMP; manufacturers then distill and dry the anesthetic to specification, perform rigorous QC (impurities, water content, identity), and fill it into dedicated, moisture-tight bottles/canisters with compliant labeling and cold-chain-free but controlled logistics. Downstream, finished product moves through pharma wholesalers and hospital procurement channels to operating rooms and ambulatory surgery centers, where it is used with anesthesia machines and calibrated vaporizers (plus carrier gases) and supported by consumables and infrastructure such as breathing circuits, CO₂ absorbents, and waste-gas scavenging systems; used anesthetic largely leaves the patient via exhalation and is routed into scavenging/disposal pathways (increasingly with capture/destruction or monitoring in some facilities), while ongoing demand is driven by surgical volumes, formulary choices, and workplace exposure and environmental management practices.
The North American market for Volatile Inhalational Anesthetics is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Volatile Inhalational Anesthetics is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Volatile Inhalational Anesthetics include Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Volatile Inhalational Anesthetics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Volatile Inhalational Anesthetics. The Volatile Inhalational Anesthetics market size, estimates, and forecasts are provided in terms of sales volume (Tons) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Volatile Inhalational Anesthetics market comprehensively. Regional market sizes by Type, by Application, by MAC, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Volatile Inhalational Anesthetics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Volatile Inhalational Anesthetics Market Report

Report Metric Details
Report Name Volatile Inhalational Anesthetics Market
Accounted market size in 2025 US$ 1055 million
Forecasted market size in 2032 US$ 1375 million
CAGR 3.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Heptafluoroane
  • Desflurane
  • Isoflurane
  • Others
Segment by MAC
  • Below 3%
  • Above 3%
by Application
  • Human Use
  • Animal Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by MAC, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Volatile Inhalational Anesthetics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Volatile Inhalational Anesthetics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Volatile Inhalational Anesthetics Market growing?

Ans: The Volatile Inhalational Anesthetics Market witnessing a CAGR of 3.9% during the forecast period 2026-2032.

What is the Volatile Inhalational Anesthetics Market size in 2032?

Ans: The Volatile Inhalational Anesthetics Market size in 2032 will be US$ 1375 million.

Who are the main players in the Volatile Inhalational Anesthetics Market report?

Ans: The main players in the Volatile Inhalational Anesthetics Market are Baxter, AbbVie, Piramal Critical Care, Fresenius Kabi, Halocarbon, Aspen, Pfizer, Maruishi Pharmaceutical, Jiangsu Hengrui Medicine, Lunan Pharmaceutical, Hikma Pharmaceuticals, HeBei YiPin Pharmaceutical, Dechra Pharmaceuticals, Life Sciences, Zhejiang AngLiKang Pharmaceutical, Linde Healthcare, Air Liquide, Messer

What are the Application segmentation covered in the Volatile Inhalational Anesthetics Market report?

Ans: The Applications covered in the Volatile Inhalational Anesthetics Market report are Human Use, Animal Use

What are the Type segmentation covered in the Volatile Inhalational Anesthetics Market report?

Ans: The Types covered in the Volatile Inhalational Anesthetics Market report are Heptafluoroane, Desflurane, Isoflurane, Others

1 Volatile Inhalational Anesthetics Market Overview
1.1 Product Definition
1.2 Volatile Inhalational Anesthetics by Type
1.2.1 Global Volatile Inhalational Anesthetics Market Value by Type: 2025 vs 2032
1.2.2 Heptafluoroane
1.2.3 Desflurane
1.2.4 Isoflurane
1.2.5 Others
1.3 Volatile Inhalational Anesthetics by MAC
1.3.1 Global Volatile Inhalational Anesthetics Market Value by MAC: 2025 vs 2032
1.3.2 Below 3%
1.3.3 Above 3%
1.4 Volatile Inhalational Anesthetics by Application
1.4.1 Global Volatile Inhalational Anesthetics Market Value by Application: 2025 vs 2032
1.4.2 Human Use
1.4.3 Animal Use
1.5 Global Volatile Inhalational Anesthetics Market Size Estimates and Forecasts
1.5.1 Global Volatile Inhalational Anesthetics Revenue 2021–2032
1.5.2 Global Volatile Inhalational Anesthetics Sales 2021–2032
1.5.3 Global Volatile Inhalational Anesthetics Market Average Price (2021–2032)
1.6 Assumptions and Limitations
2 Volatile Inhalational Anesthetics Market Competition by Manufacturers
2.1 Global Volatile Inhalational Anesthetics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Volatile Inhalational Anesthetics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Volatile Inhalational Anesthetics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Volatile Inhalational Anesthetics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Volatile Inhalational Anesthetics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Volatile Inhalational Anesthetics, Product Types and Applications
2.7 Global Key Manufacturers of Volatile Inhalational Anesthetics, Date of Entry into the Industry
2.8 Global Volatile Inhalational Anesthetics Market Competitive Situation and Trends
2.8.1 Global Volatile Inhalational Anesthetics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Volatile Inhalational Anesthetics Players Market Share by Revenue
2.8.3 Global Volatile Inhalational Anesthetics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Volatile Inhalational Anesthetics Market Scenario by Region
3.1 Global Volatile Inhalational Anesthetics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Volatile Inhalational Anesthetics Sales by Region: 2021–2032
3.2.1 Global Volatile Inhalational Anesthetics Sales by Region: 2021–2026
3.2.2 Global Volatile Inhalational Anesthetics Sales by Region: 2027–2032
3.3 Global Volatile Inhalational Anesthetics Revenue by Region: 2021–2032
3.3.1 Global Volatile Inhalational Anesthetics Revenue by Region: 2021–2026
3.3.2 Global Volatile Inhalational Anesthetics Revenue by Region: 2027–2032
3.4 North America Volatile Inhalational Anesthetics Market Facts & Figures by Country
3.4.1 North America Volatile Inhalational Anesthetics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Volatile Inhalational Anesthetics Sales by Country (2021–2032)
3.4.3 North America Volatile Inhalational Anesthetics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Volatile Inhalational Anesthetics Market Facts & Figures by Country
3.5.1 Europe Volatile Inhalational Anesthetics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Volatile Inhalational Anesthetics Sales by Country (2021–2032)
3.5.3 Europe Volatile Inhalational Anesthetics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Volatile Inhalational Anesthetics Market Facts & Figures by Region
3.6.1 Asia Pacific Volatile Inhalational Anesthetics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Volatile Inhalational Anesthetics Sales by Region (2021–2032)
3.6.3 Asia Pacific Volatile Inhalational Anesthetics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Volatile Inhalational Anesthetics Market Facts & Figures by Country
3.7.1 Latin America Volatile Inhalational Anesthetics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Volatile Inhalational Anesthetics Sales by Country (2021–2032)
3.7.3 Latin America Volatile Inhalational Anesthetics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Volatile Inhalational Anesthetics Market Facts & Figures by Country
3.8.1 Middle East and Africa Volatile Inhalational Anesthetics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Volatile Inhalational Anesthetics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Volatile Inhalational Anesthetics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Volatile Inhalational Anesthetics Sales by Type (2021–2032)
4.1.1 Global Volatile Inhalational Anesthetics Sales by Type (2021–2026)
4.1.2 Global Volatile Inhalational Anesthetics Sales by Type (2027–2032)
4.1.3 Global Volatile Inhalational Anesthetics Sales Market Share by Type (2021–2032)
4.2 Global Volatile Inhalational Anesthetics Revenue by Type (2021–2032)
4.2.1 Global Volatile Inhalational Anesthetics Revenue by Type (2021–2026)
4.2.2 Global Volatile Inhalational Anesthetics Revenue by Type (2027–2032)
4.2.3 Global Volatile Inhalational Anesthetics Revenue Market Share by Type (2021–2032)
4.3 Global Volatile Inhalational Anesthetics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Volatile Inhalational Anesthetics Sales by Application (2021–2032)
5.1.1 Global Volatile Inhalational Anesthetics Sales by Application (2021–2026)
5.1.2 Global Volatile Inhalational Anesthetics Sales by Application (2027–2032)
5.1.3 Global Volatile Inhalational Anesthetics Sales Market Share by Application (2021–2032)
5.2 Global Volatile Inhalational Anesthetics Revenue by Application (2021–2032)
5.2.1 Global Volatile Inhalational Anesthetics Revenue by Application (2021–2026)
5.2.2 Global Volatile Inhalational Anesthetics Revenue by Application (2027–2032)
5.2.3 Global Volatile Inhalational Anesthetics Revenue Market Share by Application (2021–2032)
5.3 Global Volatile Inhalational Anesthetics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Company Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Baxter Volatile Inhalational Anesthetics Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AbbVie Volatile Inhalational Anesthetics Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Piramal Critical Care
6.3.1 Piramal Critical Care Company Information
6.3.2 Piramal Critical Care Description and Business Overview
6.3.3 Piramal Critical Care Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Piramal Critical Care Volatile Inhalational Anesthetics Product Portfolio
6.3.5 Piramal Critical Care Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Company Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Fresenius Kabi Volatile Inhalational Anesthetics Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Halocarbon
6.5.1 Halocarbon Company Information
6.5.2 Halocarbon Description and Business Overview
6.5.3 Halocarbon Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Halocarbon Volatile Inhalational Anesthetics Product Portfolio
6.5.5 Halocarbon Recent Developments/Updates
6.6 Aspen
6.6.1 Aspen Company Information
6.6.2 Aspen Description and Business Overview
6.6.3 Aspen Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Aspen Volatile Inhalational Anesthetics Product Portfolio
6.6.5 Aspen Recent Developments/Updates
6.7 Pfizer
6.7.1 Pfizer Company Information
6.7.2 Pfizer Description and Business Overview
6.7.3 Pfizer Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Pfizer Volatile Inhalational Anesthetics Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Maruishi Pharmaceutical
6.8.1 Maruishi Pharmaceutical Company Information
6.8.2 Maruishi Pharmaceutical Description and Business Overview
6.8.3 Maruishi Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Maruishi Pharmaceutical Volatile Inhalational Anesthetics Product Portfolio
6.8.5 Maruishi Pharmaceutical Recent Developments/Updates
6.9 Jiangsu Hengrui Medicine
6.9.1 Jiangsu Hengrui Medicine Company Information
6.9.2 Jiangsu Hengrui Medicine Description and Business Overview
6.9.3 Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Product Portfolio
6.9.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.10 Lunan Pharmaceutical
6.10.1 Lunan Pharmaceutical Company Information
6.10.2 Lunan Pharmaceutical Description and Business Overview
6.10.3 Lunan Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Lunan Pharmaceutical Volatile Inhalational Anesthetics Product Portfolio
6.10.5 Lunan Pharmaceutical Recent Developments/Updates
6.11 Hikma Pharmaceuticals
6.11.1 Hikma Pharmaceuticals Company Information
6.11.2 Hikma Pharmaceuticals Description and Business Overview
6.11.3 Hikma Pharmaceuticals Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hikma Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolio
6.11.5 Hikma Pharmaceuticals Recent Developments/Updates
6.12 HeBei YiPin Pharmaceutical
6.12.1 HeBei YiPin Pharmaceutical Company Information
6.12.2 HeBei YiPin Pharmaceutical Description and Business Overview
6.12.3 HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Product Portfolio
6.12.5 HeBei YiPin Pharmaceutical Recent Developments/Updates
6.13 Dechra Pharmaceuticals
6.13.1 Dechra Pharmaceuticals Company Information
6.13.2 Dechra Pharmaceuticals Description and Business Overview
6.13.3 Dechra Pharmaceuticals Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Dechra Pharmaceuticals Volatile Inhalational Anesthetics Product Portfolio
6.13.5 Dechra Pharmaceuticals Recent Developments/Updates
6.14 Life Sciences
6.14.1 Life Sciences Company Information
6.14.2 Life Sciences Description and Business Overview
6.14.3 Life Sciences Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Life Sciences Volatile Inhalational Anesthetics Product Portfolio
6.14.5 Life Sciences Recent Developments/Updates
6.15 Zhejiang AngLiKang Pharmaceutical
6.15.1 Zhejiang AngLiKang Pharmaceutical Company Information
6.15.2 Zhejiang AngLiKang Pharmaceutical Description and Business Overview
6.15.3 Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Product Portfolio
6.15.5 Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
6.16 Linde Healthcare
6.16.1 Linde Healthcare Company Information
6.16.2 Linde Healthcare Description and Business Overview
6.16.3 Linde Healthcare Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Linde Healthcare Volatile Inhalational Anesthetics Product Portfolio
6.16.5 Linde Healthcare Recent Developments/Updates
6.17 Air Liquide
6.17.1 Air Liquide Company Information
6.17.2 Air Liquide Description and Business Overview
6.17.3 Air Liquide Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Air Liquide Volatile Inhalational Anesthetics Product Portfolio
6.17.5 Air Liquide Recent Developments/Updates
6.18 Messer
6.18.1 Messer Company Information
6.18.2 Messer Description and Business Overview
6.18.3 Messer Volatile Inhalational Anesthetics Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Messer Volatile Inhalational Anesthetics Product Portfolio
6.18.5 Messer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Volatile Inhalational Anesthetics Industry Chain Analysis
7.2 Volatile Inhalational Anesthetics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Volatile Inhalational Anesthetics Production Mode & Process Analysis
7.4 Volatile Inhalational Anesthetics Sales and Marketing
7.4.1 Volatile Inhalational Anesthetics Sales Channels
7.4.2 Volatile Inhalational Anesthetics Distributors
7.5 Volatile Inhalational Anesthetics Customer Analysis
8 Volatile Inhalational Anesthetics Market Dynamics
8.1 Volatile Inhalational Anesthetics Industry Trends
8.2 Volatile Inhalational Anesthetics Market Drivers
8.3 Volatile Inhalational Anesthetics Market Challenges
8.4 Volatile Inhalational Anesthetics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Volatile Inhalational Anesthetics Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Volatile Inhalational Anesthetics Market Value by MAC (US$ Million), 2025 vs 2032
 Table 3. Global Volatile Inhalational Anesthetics Market Value by Application (US$ Million), 2025 vs 2032
 Table 4. Global Volatile Inhalational Anesthetics Market Competitive Situation by Manufacturers in 2025
 Table 5. Global Volatile Inhalational Anesthetics Sales (Tons) of Key Manufacturers (2021–2026)
 Table 6. Global Volatile Inhalational Anesthetics Sales Market Share by Manufacturers (2021–2026)
 Table 7. Global Volatile Inhalational Anesthetics Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 8. Global Volatile Inhalational Anesthetics Revenue Share by Manufacturers (2021–2026)
 Table 9. Global Market Volatile Inhalational Anesthetics Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 10. Global Key Players of Volatile Inhalational Anesthetics, Industry Ranking, 2023 vs 2024 vs 2025
 Table 11. Global Key Manufacturers of Volatile Inhalational Anesthetics, Manufacturing Sites and Headquarters
 Table 12. Global Key Manufacturers of Volatile Inhalational Anesthetics, Product Types and Applications
 Table 13. Global Key Manufacturers of Volatile Inhalational Anesthetics, Date of Entry into the Industry
 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Global Volatile Inhalational Anesthetics Companies by Tier (Tier 1, Tier 2, Tier 3), based on Volatile Inhalational Anesthetics Revenue, 2025
 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 17. Global Volatile Inhalational Anesthetics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 18. Global Volatile Inhalational Anesthetics Sales by Region (Tons), 2021–2026
 Table 19. Global Volatile Inhalational Anesthetics Sales Market Share by Region (2021–2026)
 Table 20. Global Volatile Inhalational Anesthetics Sales by Region (Tons), 2027–2032
 Table 21. Global Volatile Inhalational Anesthetics Sales Market Share by Region (2027–2032)
 Table 22. Global Volatile Inhalational Anesthetics Revenue by Region (US$ Million), 2021–2026
 Table 23. Global Volatile Inhalational Anesthetics Revenue Market Share by Region (2021–2026)
 Table 24. Global Volatile Inhalational Anesthetics Revenue by Region (US$ Million), 2027–2032
 Table 25. Global Volatile Inhalational Anesthetics Revenue Market Share by Region (2027–2032)
 Table 26. North America Volatile Inhalational Anesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 27. North America Volatile Inhalational Anesthetics Sales by Country (Tons), 2021–2026
 Table 28. North America Volatile Inhalational Anesthetics Sales by Country (Tons), 2027–2032
 Table 29. North America Volatile Inhalational Anesthetics Revenue by Country (US$ Million), 2021–2026
 Table 30. North America Volatile Inhalational Anesthetics Revenue by Country (US$ Million), 2027–2032
 Table 31. Europe Volatile Inhalational Anesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 32. Europe Volatile Inhalational Anesthetics Sales by Country (Tons), 2021–2026
 Table 33. Europe Volatile Inhalational Anesthetics Sales by Country (Tons), 2027–2032
 Table 34. Europe Volatile Inhalational Anesthetics Revenue by Country (US$ Million), 2021–2026
 Table 35. Europe Volatile Inhalational Anesthetics Revenue by Country (US$ Million), 2027–2032
 Table 36. Asia Pacific Volatile Inhalational Anesthetics Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 37. Asia Pacific Volatile Inhalational Anesthetics Sales by Region (Tons), 2021–2026
 Table 38. Asia Pacific Volatile Inhalational Anesthetics Sales by Region (Tons), 2027–2032
 Table 39. Asia Pacific Volatile Inhalational Anesthetics Revenue by Region (US$ Million), 2021–2026
 Table 40. Asia Pacific Volatile Inhalational Anesthetics Revenue by Region (US$ Million), 2027–2032
 Table 41. Latin America Volatile Inhalational Anesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 42. Latin America Volatile Inhalational Anesthetics Sales by Country (Tons), 2021–2026
 Table 43. Latin America Volatile Inhalational Anesthetics Sales by Country (Tons), 2027–2032
 Table 44. Latin America Volatile Inhalational Anesthetics Revenue by Country (US$ Million), 2021–2026
 Table 45. Latin America Volatile Inhalational Anesthetics Revenue by Country (US$ Million), 2027–2032
 Table 46. Middle East and Africa Volatile Inhalational Anesthetics Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 47. Middle East and Africa Volatile Inhalational Anesthetics Sales by Country (Tons), 2021–2026
 Table 48. Middle East and Africa Volatile Inhalational Anesthetics Sales by Country (Tons), 2027–2032
 Table 49. Middle East and Africa Volatile Inhalational Anesthetics Revenue by Country (US$ Million), 2021–2026
 Table 50. Middle East and Africa Volatile Inhalational Anesthetics Revenue by Country (US$ Million), 2027–2032
 Table 51. Global Volatile Inhalational Anesthetics Sales (Tons) by Type (2021–2026)
 Table 52. Global Volatile Inhalational Anesthetics Sales (Tons) by Type (2027–2032)
 Table 53. Global Volatile Inhalational Anesthetics Sales Market Share by Type (2021–2026)
 Table 54. Global Volatile Inhalational Anesthetics Sales Market Share by Type (2027–2032)
 Table 55. Global Volatile Inhalational Anesthetics Revenue (US$ Million) by Type (2021–2026)
 Table 56. Global Volatile Inhalational Anesthetics Revenue (US$ Million) by Type (2027–2032)
 Table 57. Global Volatile Inhalational Anesthetics Revenue Market Share by Type (2021–2026)
 Table 58. Global Volatile Inhalational Anesthetics Revenue Market Share by Type (2027–2032)
 Table 59. Global Volatile Inhalational Anesthetics Price (US$/kg) by Type (2021–2026)
 Table 60. Global Volatile Inhalational Anesthetics Price (US$/kg) by Type (2027–2032)
 Table 61. Global Volatile Inhalational Anesthetics Sales (Tons) by Application (2021–2026)
 Table 62. Global Volatile Inhalational Anesthetics Sales (Tons) by Application (2027–2032)
 Table 63. Global Volatile Inhalational Anesthetics Sales Market Share by Application (2021–2026)
 Table 64. Global Volatile Inhalational Anesthetics Sales Market Share by Application (2027–2032)
 Table 65. Global Volatile Inhalational Anesthetics Revenue (US$ Million) by Application (2021–2026)
 Table 66. Global Volatile Inhalational Anesthetics Revenue (US$ Million) by Application (2027–2032)
 Table 67. Global Volatile Inhalational Anesthetics Revenue Market Share by Application (2021–2026)
 Table 68. Global Volatile Inhalational Anesthetics Revenue Market Share by Application (2027–2032)
 Table 69. Global Volatile Inhalational Anesthetics Price (US$/kg) by Application (2021–2026)
 Table 70. Global Volatile Inhalational Anesthetics Price (US$/kg) by Application (2027–2032)
 Table 71. Baxter Company Information
 Table 72. Baxter Description and Business Overview
 Table 73. Baxter Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 74. Baxter Volatile Inhalational Anesthetics Product
 Table 75. Baxter Recent Developments/Updates
 Table 76. AbbVie Company Information
 Table 77. AbbVie Description and Business Overview
 Table 78. AbbVie Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 79. AbbVie Volatile Inhalational Anesthetics Product
 Table 80. AbbVie Recent Developments/Updates
 Table 81. Piramal Critical Care Company Information
 Table 82. Piramal Critical Care Description and Business Overview
 Table 83. Piramal Critical Care Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 84. Piramal Critical Care Volatile Inhalational Anesthetics Product
 Table 85. Piramal Critical Care Recent Developments/Updates
 Table 86. Fresenius Kabi Company Information
 Table 87. Fresenius Kabi Description and Business Overview
 Table 88. Fresenius Kabi Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 89. Fresenius Kabi Volatile Inhalational Anesthetics Product
 Table 90. Fresenius Kabi Recent Developments/Updates
 Table 91. Halocarbon Company Information
 Table 92. Halocarbon Description and Business Overview
 Table 93. Halocarbon Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 94. Halocarbon Volatile Inhalational Anesthetics Product
 Table 95. Halocarbon Recent Developments/Updates
 Table 96. Aspen Company Information
 Table 97. Aspen Description and Business Overview
 Table 98. Aspen Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 99. Aspen Volatile Inhalational Anesthetics Product
 Table 100. Aspen Recent Developments/Updates
 Table 101. Pfizer Company Information
 Table 102. Pfizer Description and Business Overview
 Table 103. Pfizer Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 104. Pfizer Volatile Inhalational Anesthetics Product
 Table 105. Pfizer Recent Developments/Updates
 Table 106. Maruishi Pharmaceutical Company Information
 Table 107. Maruishi Pharmaceutical Description and Business Overview
 Table 108. Maruishi Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 109. Maruishi Pharmaceutical Volatile Inhalational Anesthetics Product
 Table 110. Maruishi Pharmaceutical Recent Developments/Updates
 Table 111. Jiangsu Hengrui Medicine Company Information
 Table 112. Jiangsu Hengrui Medicine Description and Business Overview
 Table 113. Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 114. Jiangsu Hengrui Medicine Volatile Inhalational Anesthetics Product
 Table 115. Jiangsu Hengrui Medicine Recent Developments/Updates
 Table 116. Lunan Pharmaceutical Company Information
 Table 117. Lunan Pharmaceutical Description and Business Overview
 Table 118. Lunan Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 119. Lunan Pharmaceutical Volatile Inhalational Anesthetics Product
 Table 120. Lunan Pharmaceutical Recent Developments/Updates
 Table 121. Hikma Pharmaceuticals Company Information
 Table 122. Hikma Pharmaceuticals Description and Business Overview
 Table 123. Hikma Pharmaceuticals Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 124. Hikma Pharmaceuticals Volatile Inhalational Anesthetics Product
 Table 125. Hikma Pharmaceuticals Recent Developments/Updates
 Table 126. HeBei YiPin Pharmaceutical Company Information
 Table 127. HeBei YiPin Pharmaceutical Description and Business Overview
 Table 128. HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 129. HeBei YiPin Pharmaceutical Volatile Inhalational Anesthetics Product
 Table 130. HeBei YiPin Pharmaceutical Recent Developments/Updates
 Table 131. Dechra Pharmaceuticals Company Information
 Table 132. Dechra Pharmaceuticals Description and Business Overview
 Table 133. Dechra Pharmaceuticals Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 134. Dechra Pharmaceuticals Volatile Inhalational Anesthetics Product
 Table 135. Dechra Pharmaceuticals Recent Developments/Updates
 Table 136. Life Sciences Company Information
 Table 137. Life Sciences Description and Business Overview
 Table 138. Life Sciences Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 139. Life Sciences Volatile Inhalational Anesthetics Product
 Table 140. Life Sciences Recent Developments/Updates
 Table 141. Zhejiang AngLiKang Pharmaceutical Company Information
 Table 142. Zhejiang AngLiKang Pharmaceutical Description and Business Overview
 Table 143. Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 144. Zhejiang AngLiKang Pharmaceutical Volatile Inhalational Anesthetics Product
 Table 145. Zhejiang AngLiKang Pharmaceutical Recent Developments/Updates
 Table 146. Linde Healthcare Company Information
 Table 147. Linde Healthcare Description and Business Overview
 Table 148. Linde Healthcare Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 149. Linde Healthcare Volatile Inhalational Anesthetics Product
 Table 150. Linde Healthcare Recent Developments/Updates
 Table 151. Air Liquide Company Information
 Table 152. Air Liquide Description and Business Overview
 Table 153. Air Liquide Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 154. Air Liquide Volatile Inhalational Anesthetics Product
 Table 155. Air Liquide Recent Developments/Updates
 Table 156. Messer Company Information
 Table 157. Messer Description and Business Overview
 Table 158. Messer Volatile Inhalational Anesthetics Sales (Tons), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 159. Messer Volatile Inhalational Anesthetics Product
 Table 160. Messer Recent Developments/Updates
 Table 161. Key Raw Materials Lists
 Table 162. Raw Materials Key Suppliers Lists
 Table 163. Volatile Inhalational Anesthetics Distributors List
 Table 164. Volatile Inhalational Anesthetics Customers List
 Table 165. Volatile Inhalational Anesthetics Market Trends
 Table 166. Volatile Inhalational Anesthetics Market Drivers
 Table 167. Volatile Inhalational Anesthetics Market Challenges
 Table 168. Volatile Inhalational Anesthetics Market Restraints
 Table 169. Research Programs/Design for This Report
 Table 170. Key Data Information from Secondary Sources
 Table 171. Key Data Information from Primary Sources
 Table 172. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Volatile Inhalational Anesthetics
 Figure 2. Global Volatile Inhalational Anesthetics Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Volatile Inhalational Anesthetics Market Share by Type: 2025 & 2032
 Figure 4. Heptafluoroane Product Picture
 Figure 5. Desflurane Product Picture
 Figure 6. Isoflurane Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Volatile Inhalational Anesthetics Market Value by MAC (US$ Million), 2021–2032
 Figure 9. Global Volatile Inhalational Anesthetics Market Share by MAC: 2025 vs 2032
 Figure 10. Below 3% Product Picture
 Figure 11. Above 3% Product Picture
 Figure 12. Global Volatile Inhalational Anesthetics Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Volatile Inhalational Anesthetics Market Share by Application: 2025 & 2032
 Figure 14. Human Use
 Figure 15. Animal Use
 Figure 16. Global Volatile Inhalational Anesthetics Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 17. Global Volatile Inhalational Anesthetics Market Size (US$ Million), 2021–2032
 Figure 18. Global Volatile Inhalational Anesthetics Sales (Tons), 2021–2032
 Figure 19. Global Volatile Inhalational Anesthetics Average Price (US$/kg), 2021–2032
 Figure 20. Volatile Inhalational Anesthetics Report Years Considered
 Figure 21. Volatile Inhalational Anesthetics Sales Share by Manufacturers in 2025
 Figure 22. Global Volatile Inhalational Anesthetics Revenue Share by Manufacturers in 2025
 Figure 23. Top 5 and Top 10 Global Volatile Inhalational Anesthetics Players: Market Share by Revenue in Volatile Inhalational Anesthetics in 2025
 Figure 24. Volatile Inhalational Anesthetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 25. Global Volatile Inhalational Anesthetics Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 26. North America Volatile Inhalational Anesthetics Sales Market Share by Country (2021–2032)
 Figure 27. North America Volatile Inhalational Anesthetics Revenue Market Share by Country (2021–2032)
 Figure 28. United States Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Canada Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Europe Volatile Inhalational Anesthetics Sales Market Share by Country (2021–2032)
 Figure 31. Europe Volatile Inhalational Anesthetics Revenue Market Share by Country (2021–2032)
 Figure 32. Germany Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. France Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. U.K. Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Italy Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Russia Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Asia Pacific Volatile Inhalational Anesthetics Sales Market Share by Region (2021–2032)
 Figure 38. Asia Pacific Volatile Inhalational Anesthetics Revenue Market Share by Region (2021–2032)
 Figure 39. China Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Japan Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. South Korea Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. India Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Australia Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. China Taiwan Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Southeast Asia Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Latin America Volatile Inhalational Anesthetics Sales Market Share by Country (2021–2032)
 Figure 47. Latin America Volatile Inhalational Anesthetics Revenue Market Share by Country (2021–2032)
 Figure 48. Mexico Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Brazil Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Argentina Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Colombia Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Volatile Inhalational Anesthetics Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Volatile Inhalational Anesthetics Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. UAE Volatile Inhalational Anesthetics Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Volatile Inhalational Anesthetics by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Volatile Inhalational Anesthetics by Type (2021–2032)
 Figure 59. Global Volatile Inhalational Anesthetics Price (US$/kg) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Volatile Inhalational Anesthetics by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Volatile Inhalational Anesthetics by Application (2021–2032)
 Figure 62. Global Volatile Inhalational Anesthetics Price (US$/kg) by Application (2021–2032)
 Figure 63. Volatile Inhalational Anesthetics Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS